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Abstract
The fusion of villous cytotrophoblasts into the multinucleated syncytiotrophoblast
is critical for the essential functions of the mammalian placenta. Using RNA-Seq
gene expression, quantitative protein expression, and siRNA knockdown we identified genes and their cognate proteins which are similarly upregulated in two cellular models of mammalian syncytia development (human BeWo cytotrophoblast to
syncytiotrophoblast and murine C2C12 myoblast to myotube). These include DYSF,
PDE4DIP, SPIRE2, NDRG1, PLEC, GPR146, HSPB8, DHCR7, and HDAC5. These
findings provide avenues for further understanding of the mechanisms underlying
mammalian placental syncytiotrophoblast development.
KEYWORDS
cell fusion, placenta, syncytialization

Funding information
National Center for Research Resources
(NCRR), Grant/Award Number: UL1
TR000448; NCI Cancer Center Support
Grant, Grant/Award Number: #P30
CA91842

1

|

IN T RO D U C T IO N

The human placenta performs many of the diverse functions
that control maternal metabolism relating to fetal growth
and development that mediate the survival of the offspring.
Placental dysfunction accompanies many disorders of pregnancy and underlies both short-term and long-term sequelae
for the fetus-newborn-child-adult.
Fusion of the underlying placental cytotrophoblasts forms
the syncytotrophoblast which is a multinucleate continuous

layer covering the large placental villous surface. Importantly,
the mechanisms that govern the transition of villous cytotrophoblasts into syncytiotrophoblast (i.e., syncytium formation) are central to understanding the physiological and
pathological roles of this key maternal-fetal interface.
Syncytia formation is a highly specialized and essential
process for mammalian placental development, muscle development, and formation of osteoclasts from macrophages.
In addition, syncytia are a common feature of mammalian infection with enveloped viruses including lentivirus,
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coronavirus, paramyxovirus, and some herpes viruses. In
each of these cell-cell fusion systems, many molecules are involved to varying degrees, although the magnitude to which
they participate is not always clear.
Perhaps the best-studied mammalian system of syncytia
formation is that of myoblast fusion to form multi-nucleate
myotubes and ultimately myofibers (Petrany & Millay, 2019;
Schejter, 2016). Myoblast fusion is driven by two independent skeletal muscle-specific proteins, myomaker, and myomixer/myomerger, whose expression is tightly regulated
and which function at distinct steps in the fusion process (Bi
et al., 2017; Millay et al., 2013). Other effectors of myoblast
fusion include the actin cytoskeleton, phosphatidylserine

(PS) exposure, membrane PS receptors, ferlin proteins,
and the RAC1/ELMO/BAI3/Dock1 pathway (Petrany &
Millay, 2019).
The fusion of placental cytotrophoblasts is tightly regulated throughout pregnancy (Simpson et al., 1992). Yet, the
processes that regulate cytotrophoblast fusion with syncytotrophoblast are largely unknown. Mediators associated with
cytotrophoblast fusion include syncytin-1 and syncytin-2 and
their receptors, SLC1A5 and MFSD2A, respectively (Blaise
et al., 2003; Blond et al., 2000; Bolze et al., 2017; Huppertz
& Gauster, 2011; Lavillette et al., 2002; Mi et al., 2000).
Syncytin-1 and syncytin-2 are fusogenic Env glycoproteins
of human endogenous retroviral origin. Initially identified
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F I G U R E 1 RNA-Seq gene expression heat maps of triplicate samples for C2C12 cells at 0d (mb) and 6d (mt) in differentiation media. In the
plot, the arrowhead denotes the sample used to order the heat map
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R E S U LTS

BeWo cytotrophoblast cells form syncytia upon forskolin treatment in vitro. Incubation with 100 µM forskolin for 72 hrs induces marked syncytia formation, as we have shown previously
(Wice et al., 1990). C2C12 myoblast cells form syncytia upon
differentiation in vitro. Incubation with 2% horse serum-containing DMEM for 6d induces marked syncytia formation, as we
have shown previously (Sun et al., 2005).

2.1 | RNA-Seq analysis of BeWo cells and
C2C12 cells
RNA-Seq was performed on triplicate preparations of BeWo
cells at 0 hr and 72 hrs in the absence of forskolin (cyt) and

|
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by Mi et al. (2000) and Blond et al. (2000), syncytin-1 is
a member of the HERV-W family and supports homo- and
heterotypic fusion when expressed in cell lines expressing
the syncytin-1 receptor, SLC1A5 (Lavillette et al., 2002).
Knockout of the murine homolog of syncytin-1 (i.e., syncytin-A) results in the defective placental structure including
excess unfused cytotrophoblasts and embryonic lethality by
13.5 dpc (Dupressoir et al., 2009). However, the presence
of syncytin-1 and its receptor in human cytotrophoblast cell
lines is, in itself, insufficient for trophoblast fusion (Kudo
et al., 2003). Using RNA-Seq gene expression and quantitative protein expression we recently identified six upregulated (hCGβ, FLRG, CRIP2, TREML2, PAM, INHA) and
five downregulated (SERPINF1, SAA1, C17orf96, KRT17,
MMP19) genes in two cellular models of cytotrophoblast to
syncytiotrophoblast development, primary human villous
and human BeWo cytotrophoblasts (Azar et al., 2018).
Villous cytotrophoblasts isolated from human term placentas undergo differentiation and fusion into syncytia
during culture (Azar et al., 2018; Kliman et al., 1986; Nelson
et al., 1999). Moreover, the human trophoblast choriocarcinoma BeWo b30 responds to signals for fusion; we showed
that cyclic AMP signaling markedly enhanced syncytia formation and hormonal differentiation (Orendi et al., 2010;
Wice et al., 1990). The murine C2C12 myoblast cell line
also undergoes triggered differentiation and regulated syncytia formation to myotubes in vitro (Petrany & Millay, 2019;
Schejter, 2016). Herein, we exploit the power of these two
cell models (BeWo, C2C12) to utilize an unbiased approach
to identify genes, and their protein products, which are similarly upregulated in the two mammalian cell systems that
reflect cell-cell fusion and syncytia formation. We undertook
this study with the expectation that common mechanisms or
pathways would be found in myoblast fusion and cytotrophoblast fusion.

   

PC1 (89.6%)

F I G U R E 2 Principle components analysis of C2C12 cell gene
expression data. Analysis was performed in R. The first and second
principal components are plotted on the x- and y-axis, respectively

at 24 hrs, 48 hrs, and 72 hrs (syn) in the presence of forskolin. RNA-Seq was performed on triplicate cultures of C2C12
cells at 0d (mb) and 6d (mt) in differentiation media. There
was a remarkable similarity in overall gene expression levels
among the three samples at each of the time points (Figure 1
and Azar et al., 2018). There were substantial differences
between the 0d and 6d C2C12 cells and between the BeWo
cells ∓ forskolin at 72 hrs as shown via principle component
analysis (Figure 2 and Azar et al., 2018). This pattern was
exactly as anticipated, with minor differences between samples at the same time points in contrast with the much larger
differences between time points. This captures the different
transcriptional programs in place in cytotrophoblasts/syncytiotrophoblasts, and myoblasts/myotubes.
To determine the genes differentially expressed in the
6d C2C12 myotubes (differentiated) versus the 0d C2C12
myoblasts (undifferentiated), we analyzed the 50 most upregulated genes in these two phenotypes. Not surprisingly,
a number of the most upregulated genes during the C2C12
transition from myoblast to myotube were involved in muscle contractile machinery (Figure 3), whereas BeWo cells
displayed numerous histone and ribosomal protein genes
(Azar et al., 2018). Using PANTHER (Mi et al., 2016), we
rigorously characterized the pathways and gene families in
our samples. Changes in expression in C2C12 cells at 0d and
6d in differentiation media were compared with the results
of those we previously reported for BeWo cells ± forskolin
(Azar et al., 2018). While the gene ontology terms that were
significantly enriched in the genes we analyzed in BeWo
cells included sex differentiation, reproduction, tissue development, and amino acid transport, in C2C12 cells the terms
most enriched in the genes we analyzed involved, perhaps not
surprisingly, muscle development and muscle contraction.

|   

4 of 16

AZAR et al.

a

b

Most highly expressed genes in BeWo

Most highly expressed genes in C2C12

RPL14

Mylpf

KRT8

mt−Atp8

EIF4G2

Rpl13a

RPL38

Tpm2

EEF2

Acta1

FTL

Lgals1

ATP8

Cox7b

RPLP1

Tmsb10

GNB2L1

Gpx4

NME2

Rplp1

PGF

Uba52

HIST2H2AA3

mt−Co3

RPL35

Tnnc1

EIF4A1

Myl1

SQSTM1

Ncam1

PDIA3

Ccdc107

TMED9

Mif

RPS14

Tuba1a

RPL13A

mt−Nd4l

SLC3A2

mt−Co1

RPL27A

Hist1h4h

HNRNPH1

Expression

Hist1h4a

UBA52

7.5

ND3
KRT18

5.0

RPL36

2.5

HSD17B4
RPLP2

Expression

Tnnc2

10.0

Mouse Gene

Human Gene

HIST1H2BK

10.0

Aldoa
Rps8

7.5

Ubc

5.0

Rps14

2.5

Rps15a
S100a4

RPL23

Tnni1

TARS

Gnai2

RPS19

Rpl36

RPS21

Rpl6

RPS8

Tnni2

RPL37A

Rps21

HIST2H3D

mt−Nd1

COPE

Myl4

G3BP1

Rack1

HIST2H4A

Mt1

RPS11

Vim

UAP1

mt−Atp6

CCT5

Des

RPL6

Acta2

RPL12

Crip1

TMSB10

Atp5b

SLC40A1

Rpl23

ND4L

S100a11

COX2

Actc1

LOC728026

Tpm1

PTMA

Eef2
cyt

syn

mb

mt

cyt

syn

mb

mt

F I G U R E 3 The most highly expressed genes in (a) BeWo cells and (b) C2C12 cells. In each panel, the 50 most highly expressed genes in the
indicated sample were selected and used to sort the heat map. The expression levels of those genes in each of the other samples is also shown

Other enriched pathways included cytoskeletal organization
and cell cycle processes. A complete list of significant pathways is included in the PANTHER Analysis Data File.
The data from these two systems demonstrate that
there are distinct similarities and differences, as expected,

to the formation of syncytia in these two cellular models.
Encouragingly, several of the differentially regulated genes
in the myoblast to myotube transition in C2C12 cells and
in the cytotrophoblast to syncytiotrophoblast transition in
BeWo cells overlap. This lends support to the use of both of
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F I G U R E 4 The set of genes that is differentially expressed upon fusion in both C2C12 and BeWo cells. Each gene that met our fold change
and expression criteria was plotted by its fold change in C2C12 cells cultured in differentiation media from 0d (mb) to 6d (mt) on the x-axis and the
fold change in BeWo -forskolin (cyt) or +forskolin (syn) for 72h on the y-axis. Only genes that were upregulated in both samples were retained

T A B L E 1 Description of
antibodies used for immunoblots,
immunohistochemistry, and
immunofluorescence

Protein

MW
kDa

Company

Antibody

Host

Lot #

DYSF

237

Abcam

ab124684

Rabbit m

GR211867-33

PDE4DIP

265

Sigma

HPA008162

Rabbit p

A89686

80

Invitrogen

PA5-24099

Rabbit p

UC2732201A

43

Biorbyt

orb381904

Rabbit p

QA2100

523

NSJ Bio

R32233

Rabbit p

R32233-413052

SPIRE2
NDRG1
PLEC
GPR146

37

Invitrogen

PA5-27175

Rabbit p

UE2775116A

HSPB8

22

Invitrogen

PA5-76780

Rabbit p

UC2732613A

DHCR7

54

Abcam

ab103296

Rabbit p

GR3225939-4

HDAC5

122

Abcam

ab55403

Rabbit p

GR36969-13

actin

42

Sigma

A5441

Mouse m

064M4789V

MHC

200

Santa Cruz

sc-376157

Mouse m

A0819

hCGβ

18

Abcam

ab3976

Rabbit p

GR254346-B

ZO-1

220

Invotrogen

40–2200

Rabbit p

UB280595

Note: In host column p = polyclonal, m = monoclonal.

these models and suggests that, despite differences, both are
capturing important and shared aspects of the syncytialization process.
To best capture the genes that are critical for syncytialization, we combined our C2C12 differentiation and BeWo
differentiation datasets into a joint analysis. To do this, we
first stringently filtered each dataset independently, keeping
only genes that were expressed at ≥85th percentile for at

least one time point, while also showing greater than 2.5-fold
change between myoblast/myotube and cytotrophoblast/syncytiotrophoblast. We subsequently plotted the genes as points
determined on their fold change in C2C12 myoblast/myotube
on the x-axis by fold change in BeWo cytotrophoblast/syncytiotrophoblast on the y-axis (Figure 4). Viewed this way,
nine genes were upregulated under both conditions and we
selected these nine genes for further analysis.
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Summary of expression data from RNA-Seq and quantified immunoblot results shown in Figures 5, 6
BeWo Expression
RNA

C2C12 Expression
Protein

RNA

Protein

Gene

cyt

syn

Fold
Change

cyt

syn

Fold
Change

mb

mt

Fold
Change

mb

mt

Fold
Change

DYSF

0.26

6.6

25

0.51

1.5

2.9

0.38

7.3

19

0.003

2.4

>100

PDE4DIP

2.0

46

23

0.91

1.5

1.6

0.70

20

29

0.94

1.2

1.3

NDRG1

1.6

15

9.4

1.1

0.91

0.83

0.43

5.2

12

0.67

1.7

2.5

PLEC

12

72

6.0

0.05

2.2

44

9

63

7.0

0.19

1.4

7.4

SPIRE2

1.9

26

14

0.75

1.2

1.6

2.4

7.3

3.0

1.2

0.92

0.77

HSPB8

22

139

6.3

0.23

2.1

9.1

41

177

4.3

0.03

2.3

77

GPR146

7.8

68

8.7

1.3

0.75

0.58

1.9

6.3

3.3

0.51

1.7

3.3

DHCR7

6.4

20

3.1

1.0

0.89

0.89

2.0

7.5

3.8

0.21

2.2

10

HDAC5

26

154

5.9

1.5

0.57

0.38

3.9

11

2.8

0.43

1.8

4.2

Note: Data for BeWo cells –forskolin (cyt) or + forskolin (syn) and C2C12 cells at 0d (mb) or 6d (mt) in differentiation media are shown. Increases or decreases in
expression are given as fold change.

2.2 | Protein expression in C2C12 (0d vs.
6d) and BeWo (±forskolin) cells
In order to determine if the changes in RNA levels (i.e., RNASeq expression) in C2C12 (0d vs. 6d) and BeWo (±forskolin) are reflected in the levels of the respective proteins, we
performed quantitative Western blot analysis of C2C12 cell
lysates at 0d and 6d and BeWo cell lysates at 72 hrs ±forskolin. We selected individual antibodies that recognize both
the human and murine proteins. Table 1 lists the specific
antibodies used for these analyses. As seen in Figures 5, 6,
and Table 2, for the nine genes which are upregulated, the
increase in protein expression in cell lysates generally correlated with the increase in RNA expression.

2.3 | Effect of siRNA knockdown of
hCGβ and dysferlin in BeWo cells
As dysferlin was the most upregulated gene in both BeWo
and C2C12 cells (Figure 4), and hCGβ is the most upregulated gene in BeWo cells (Azar et al., 2018) we next
examined the effects of hCGβ knockdown and dysferlin knockdown in BeWo cells treated with forskolin for
72 hrs. As seen in Figure 7, knockdown of hCGβ markedly
(>95%) reduced cellular hCGβ levels in cells treated with
forskolin. Surprisingly, cellular dysferlin levels were also
markedly reduced. Knockdown of dysferlin also markedly
(>95%) reduced cellular dysferlin levels in cells treated
with forskolin, whereas hCGβ levels were largely preserved. Under both conditions (i.e., hCGβ knockdown or
dysferlin knockdown), however, BeWo cell fusion was unaffected (Figure 7). (p > .05 control vs. hCGβ knockdown
vs. dysferlin knockdown).
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DISCUSSION

Syncytia formation is a highly specialized and indispensable process for mammalian placental development and
muscle development. The data herein show a comprehensive, unbiased RNA-Seq screen that identified genes that
likely play a role in syncytia development in placental cytotrophoblast to syncytiotrophoblasts and in muscle myoblast to myotubes. The RNA-Seq analysis was performed
on samples from two complementary and biologically
relevant in vitro model systems of syncytialization: forskolin-induced differentiation of cytotrophoblasts to syncytiotrophoblasts in the human choriocarcinoma-derived
cell line, BeWo and growth factor depletion-induced differentiation of myoblasts to myotubes in the murine skeletal muscle-derived cell line, C2C12. We selected these as
among the best characterized mammalian cell systems, recognizing one is human (BeWo), the other murine (C2C12).
One potential benefit thereof is the additional selection
criterion of the conservation of genes/proteins across species. We used stringent criteria to identify the most highly
upregulated genes in the two model systems interrogated
from the RNA-Seq data. We identified nine genes from this
analysis and pursued the evaluation of protein expression
of each of these in the BeWo and C2C12 systems via quantitative Western blot analysis. The data show that the RNA
and protein expression levels do not correlate uniformly.
Many of the nine upregulated genes encode proteins
involved in cytoskeletal dynamics, while others regulate
cellular functions. Mutants of many are associated with
muscle disorders. Dysferlin (DYSF, ~237kDa) is strongly
expressed in skeletal muscle and placenta in addition to
heart and brain(Liu et al., 1998). In mature skeletal muscle, dysferlin localizes to the plasma membrane, whereas in

AZAR et al.

   

a
BeWo

8

C2C12

2.0

10
8

6

6

4

4
2

cyt

syn

mb

mt

0

extracts

BeWo

C2C12

3

1.5

2

0

7 of 16

Protein

DYSFProtein
Expression

DYSFRNA
Expression(TPM)

b

RNA

|

2

1.0
1

0.5

0.0
lysates

cyt

syn

mb

0

mt

DYSF

50

25

2.5

40

20

2.0

30

15

20

10

10

5

0

cyt

syn

mb

mt

0

extracts

PDE4DIPProtein
Expression

PDE4DIPRNA
Expression(TPM)

actin

2

1.5

1

1.0
0.5

0.0
lysates

cyt

syn

mb

mt

0

PDE4DIP

25

10

20

8

15

6

10

4

5

2

0

cyt

syn
mb
extracts

mt

0

NDRG1Protein
Expression

NDRG1RNA
Expression(TPM)

actin
1.5

3

1.0

2

0.5

1

0.0
lysates

cyt

syn

mb

mt

0

NDRG1
actin

F I G U R E 5 (a) RNA-Seq analysis and (b) quantitative Western blot analysis of the three most upregulated genes of interest in BeWo cells
-forskolin (cyt) or +forskolin (syn) and C2C12 cells in differentiation media at 0d (mb) or 6d (mt). RNA-Seq results are expressed in transcripts per
million (TPM). Immunoblots were quantified and normalized to levels of actin; note, multiple panels in Figures 5 and 6 used the same actin control

C2C12 myotubes it is found in T-tubules but translocates to
the plasma membrane upon damage. Dysferlin has numerous binding partners, including caveolin-3/MG53 as well
as AHNAK/annexin/actin complexes (Lek et al., 2012).
Dysferlin is mutated in Miyoshi myopathy and limb-girdle
muscular dystrophy (Bansal et al., 2003; Liu et al., 1998).
Robinson et al. (2009), demonstrated dysferlin expression in

the apical plasma membrane of human placental syncytiotrophoblast and increased dysferlin expression in BeWo cells
treated with forskolin, suggesting a relationship between cytotrophoblast fusion and dysferlin expression. Furthermore,
dysferlin knockout mice are viable, fertile, and have a normal growth rate (Bansal et al., 2003). Phosphodiesterase 4D
interacting protein, (PDE4DIP, also known as myomegalin,
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F I G U R E 6 (a) RNA-Seq analysis and (b) quantitative Western blot analysis of the six remaining upregulated genes of interest in BeWo cells –
forskolin (cyt) or + forskolin (syn) and C2C12 cells in differentiation media at 0d (mb) or 6d (mt). RNA-Seq results are expressed in transcripts per
million (TPM). Immunoblots were quantified and normalized to levels of actin; note, multiple panels in Figures 5 and 6 used the same actin control
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F I G U R E 7 Effect of siRNA knockdown of hCGβ or DYSF expression on the syncytialization of BeWo cells. (a) Representative double-label
immunofluorescence of BeWo cytotrophoblasts (left) and syncytiotrophoblasts (right). BeWo cells -forskolin (cyt) or +forskolin (syn), were fixed,
and nuclei were stained with DAPI (shown in magenta), while cell junctions were stained with anti-ZO1 antibody (pseudo-colored in yellow).
Insets of syncyntia shown on the right were magnified 2-fold. (b) Results of nuclei counts used to determine percent syncytialization and (c)
representative Western blots of BeWo cells transfected with siRNA targeting the genes indicated (hCGβ and DYSF) and treated with either vehicle
(cyt) or forskolin (syn) for 72h as described in Materials and Methods

~260 kDa) anchors PDE4 to the centrosome-Golgi region
and is in sarcomeres of skeletal muscle and heart (Verde
et al., 2001). Knockout of PDE4DIP’s DUF1220 domain

reduced fecundity to ~68% of predicted offspring (Filleur
et al., 2009). Spire type actin nucleation factor 2 (SPIRE2,
80 kDa), a cytoplasmic actin nucleation factor, provides a
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link between actin cytoskeletal dynamics and intracellular
transport (Schuh, 2011). N-myc downstream-regulated gene
1 (NDRG1, 43kDa) is the most ubiquitous member of the
NDRG family, expressed in the cytoplasm and nucleus and
the only family member expressed in placenta. We previously
showed that NDRG1 attenuates hypoxic injury to human trophoblasts (Chen et al., 2006). Expression of NDRG1 (also
termed RTP) is markedly increased in BeWo cells following
forskolin treatment (Xu et al., 1999). In addition, mutations
in NDRG1 are associated with Charcot-Marie-Tooth disease
type 4D. NDRG1 knockout mice were born with the normally expected Mendelian frequency, were viable, and were
fertile (Okuda et al., 2004). Plectin (PLEC, ~500kDa), a cytoplasmic protein, is widely expressed in muscle, placenta,
and heart where it interacts with cytoskeletal components including actin, microtubules, intermediate filaments, and the
plasma membrane (Rezniczek et al., 2016). Plectin knockout
mice are viable but die at 2–3 days and exhibit marked skin
abnormalities. GPR146 (37 kDa), an orphan G protein-coupled receptor, has been proposed as a C-peptide receptor.
Most recently, Yu et al. (2019) showed that GPR146 regulates plasma cholesterol levels via ERK signaling and that
GPR146 knockout mice are viable and fertile. Heat shock
protein HSPB8 also known as HSP22 (22 kDa) is a cytoplasmic protein that serves as a member of the chaperone-assisted
autophagy complex and is involved in Charcot-Marie-Tooth
disease type 2L as well as in a rare form of human distal
myopathy (Ghaoui et al., 2016). HSPB8 knockout mice are
viable (Qiu et al., 2011). 7-dehydrocholesterol reductase
(DHCR7, 54 kDa) catalyzes the final step in cholesterol biosynthesis, the conversion of dehydrocholesterol to cholesterol, primarily within the endoplasmic reticulum of virtually
all tissues. Mutations in DHCR7 are associated with SmithLemli-Opitz Syndrome (Wassif et al., 1998) and null variants
are viable as a result of maternal to fetal cholesterol transport.
Histone deacetylase 5 (HDAC5, 122 kDa) deacetylates target
lysine residues of core histones and thus provides epigenetic regulation of numerous developmental events including
suppressing transcription of MEF2C during muscle differentiation (McKinsey et al., 2000). HDAC5 knockout mice are
viable and fertile (Chang et al., 2004).
The fusion of villous cytotrophoblasts throughout pregnancy generates syncytiotrophoblast with a ~10M2 surface
area (Bolze et al., 2017). While villous cytotrophoblast to
syncytiotrophoblast fusion requires syncytin-1 and syncytin-2 and their ubiquitous receptors, membrane transporters
SLC1A5 and MFSD2A in humans, many additional factors including PS exposure and annexin A5 are required for
cytotrophoblast fusion (Degrelle et al., 2017; Huppertz &
Gauster, 2011).
The fusion of skeletal muscle myoblasts to form multinucleated myotubes and ultimately myofibers occurs throughout the lifetime of the muscle and allows regeneration and
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adaptation to exercise. Myomaker and myomixer/myomerger
are essential for vertebrate muscle formation. Myomaker/
myomixer expression and activity are highly regulated to
the time and place of myoblast fusion during development.
One current stepwise model supports myomaker as necessary
for hemifusion whereas myomixer mediates pore formation
(Petrany & Millay, 2019). When co-expressed, myomaker
and myomixer drive fibroblast fusion, indicating that the
combination of the two proteins can perform the steps necessary for fusion. However, other factors identified may act
at different stages of the process and include actin cytoskeletal remodeling, PS exposure, BAI1 and stabilin 2 membrane
PS receptors, VASp/Stlr/Arp2/3, annexins, cadherins, ferlin
proteins, the RAC1/ELMO/BAI3/Dock 1 pathway (Petrany
& Millay, 2019).
For our analysis, we selected antibodies that recognized
both human and murine protein species of our nine candidate genes. Of note, all of these nine proteins are enriched in
syncytiotrophoblast surrounding the villi of normal human
placenta (Figure 8). Taken together, we conclude that the
activities of these nine similarly regulated gene products do
not appear to behave as a single uniform function during the
transition from mononucleated cytotrophoblast to differentiated syncytiotrophoblast and from myoblast to myotube, and
likely upregulation of some is required for fusion, while upregulation of others is a result of fusion, or unrelated to the
fusion process per se. Indeed, future analyses of serum-depletion or forskolin treatment of myomaker-deficient (fusion
incompetent) C2C12 cells may provide insight into this.
Gene expression changes have been examined in BeWo
cells (Kudo et al., 2004; Shankar et al., 2015; Zheng
et al., 2017) during forskolin treatment. Kudo et al. (2004)
used microarray and RNA-Seq analysis to track up or downregulation of gene expression and kinetic changes during the
trophoblast formation of syncytium. Zheng et al. (2017) performed RNA-Seq yielding data for BeWo cells (of the parent
choriocarcinoma cell line) to identify and cluster differentially expressed genes. Shankar et al. (2015) augmented their
RNA-Seq data with DNA methylation and ChIP-seq assays
to generate a more complete epigenetic profile of BeWo cytotrophoblasts and syncytiotrophoblasts.
Several previous studies have explored the transcriptional
changes that occur during the transition from myoblasts
to myotubes in C2C12 cells. Moran et al. (2002) used microarrays to interrogate gene expression levels in these cells
at several timepoints during differentiation. They used this
time and expression data to cluster genes into groups based
on their expression profile. They found that these clusters of
genes were enriched for genes involved in cell-cycle regulation, muscle contraction, cytoskeletal organization, and cellular metabolism. Our results herein are consistent with those
of Moran et al. (2002); that is, many of the same functional
classes were found to be overrepresented in both studies.
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F I G U R E 8 Immunochemical staining of normal term human placental villi. Serial sections of normal term human placental villi samples were
immunostained with antibodies to upregulated proteins and hematoxylin & eosin, as indicated. Robust HRP staining of syncytiotrophoblasts is
clearly visible for upregulated proteins

More recently, Trapnell et al. (2010) used RNA-Seq to explore the transcriptional changes in C2C12 myoblasts and
myotubes. While the primary goal of that work was to detect
novel transcripts and unannotated isoforms, the differentially
expressed and differentially spliced genes that they discuss
are again consistent with our findings. Several other papers
have explored the role of MyoD1, PPARɣ, and other transcription factors critical for the differentiation process (He
et al., 2017; Shintaku et al., 2016). These also show that the
transcriptional changes orchestrated by these transcription
factors affect the same genes that we found to be differentially regulated. In contrast to previous works, our current
study explicitly looks at the process of syncytialization. This
is one necessary step in the formation of myotubes that has
not been well-characterized. By comparing the differentially
expressed transcripts between myoblasts and myotubes with
the differentially expressed transcripts between cytotrophoblasts and syncytiotrophoblasts, we are able to identify those

transcripts that may play a direct role in the syncytialization
process.
The most upregulated gene and protein expression
during placental development is hCGβ. Yet, the literature
is inconsistent in the relationship between cytotrophoblast
fusion and hCGβ expression. Saryu Malholtra et al. (2015)
have suggested that the knockdown of hCGβ in BeWo cells
is associated with reduced forskolin-induced cell fusion.
Dysferlin was the most upregulated gene and protein expression in both C2C12 and BeWo cells as described above
(Figure 4). Robinson et al. (2009) have shown that dysferlin is expressed primarily in syncytiotrophoblast in the
human placenta and that expression of dysferlin correlated
with forskolin-induced fusion of BeWo cytotrophoblasts.
Following dysferlin knockdown, Omata et al. (2013) have
reported BeWo cell fusion is unaltered. Our results show
that following the knockdown of either hCGβ or dysferlin
in BeWo cells, forskolin-induced syncytia formation (i.e.,
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cell fusion) was unaltered (Figure 7). Thus, these results
argue that neither hCGβ nor dysferlin upregulation is essential for syncytia formation.
Ultimately, for both muscle and placental syncytia formation programs, it will be essential to understand whether
(a) each factor upregulates positive effectors, downregulates
negative effectors or post translationally regulates essential
effectors, as well as whether (b) each factor is a true membrane-active driver of fusion, a fusion-assisting molecule or
gene product that is upregulated as a result of fusion that may
be required for the proper function of the syncytia (Brukman
et al., 2019; Petrany & Millay, 2019).

4
4.1

|

M ATE R IA L S A N D ME T HODS

|

Cells and culture

BeWo b30 cells were cultured in F-12K Nutrient Mix,
Kaighn's Modification (Gibco), 10% FBS, and 2mM glutamine (Wice et al., 1990). At 10% confluency, media was
replaced with fresh media containing either 1% DMSO (control) or 100 µM forskolin in DMSO at 0 hr, 24 hrs, or 48 hrs
as indicated. At the appropriate time, cells, media or both
were harvested for RNA-Seq, protein analysis or immunofluorescence as indicated.
C2C12 mouse myoblast cells were obtained from ATCC
and routinely propagated in growth media (Dulbecco's
Modified Eagle's Medium (DMEM) (Sigma) supplemented
with 10% FBS). Myogenic differentiation to myotubes was
induced by changing to differentiation media (DMEM supplemented with 2% horse serum) when the cells reached confluence. Cells were maintained in differentiation medium for
6 days with medium changed every 24 hrs (Sun et al., 2005).
At the appropriate time (0d for myoblasts, 6d for myotubes)
cells were harvested for RNA-Seq, protein analysis or immunofluorescence as indicated.

4.2

|

Protein analysis

For cellular protein analysis, BeWo or C2C12 cells were
rinsed in PBS at 4°C and thereafter incubated for 20 min
at 4°C with fresh lysis buffer, followed by centrifugation
(15 min at 13,000 rpm at 4°C), and the resultant supernatant
was stored at −20°C, as described previously (Trausch-Azar
et al., 2015). Western blot analysis following SDS-PAGE
was performed on aliquots and probed with antibodies as
described in the text and Table 1. Actin content was evaluated on each set of lysates as a control and for normalization, as indicated in the respective Figures 5, 6, and 9.
Myosin heavy chain and hCGβ expression served as differentiation markers for myotubes and syncytiotrophoblasts,
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respectively. Western blots were developed with Pierce
ECL Western Blotting Substrate, SuperSignal West Femto
Maximum Sensitivity Substrate from Thermo Scientific or
Bio-Rad Clarity Western Blot ECL Substrate. Western Blots
were quantitated using Image J software (https://imagej.nih.
gov/ij/docs/faqs.html) and results were normalized to actin.
Analyses were performed on at least three independent preparations of BeWo and C2C12 cells (see Figures 5, 6, and 9).

4.3

|

siRNA knockdown analysis

BeWo cells were transfected using nucleofection, an electroporation-based system. Cells were cultured as described
above in 10cm dishes until 80%–90% confluent then trypsinized and counted. 10 × 106 cells/ml were resuspended in
cell line solution V and 1 × 106 cells were transfected with
10 μl of a 20 μM solution of the indicated siRNA (Santa Cruz
Biotechnology, USA) following the manufacturer's instructions using program A-020 (Lonza, Switzerland). Following
transfection, cells were plated in 6 well plates. After 24 hr,
72 hrs forskolin treatment was begun and cells were harvested
at indicated times as described above. Transfections and time
courses were performed in duplicate in each experiment.

4.4

|

Immunofluorescence analysis

For immunofluorescence analysis and as described previously (Azar et al., 2018; Trausch-Azar et al., 2015; Wice
et al., 1990). BeWo cells were seeded onto glass coverslips
in six-well dishes and treated with forskolin or DMSO as described above. Cells were then washed with PBSc, fixed with
4% paraformaldehyde, and permeabilized in 1% Triton-X
100. After blocking in 1% BSA/PBSc, coverslips were immunostained with primary antibody to determine subcellular
localization. After washing with PBSc, coverslips were incubated with the appropriate Alexa Fluor 488 or 568 secondary antibodies (Invitrogen/Molecular Probes) and DAPI and
mounted using Mowiol containing 2.5% 1, 4-diazo-bicyclo[2.2.2]-octane (DABCO, Sigma).
Images of fixed cells were captured using a Nikon Eclipse
Ti-E inverted confocal microscope equipped with a 20X air objective lens (Nikon, Melville, NY). A series of digital optical
fields (4 × 4) were captured using an Andor Neo-Zyla CMOS
camera at room temperature. Optical fields were stitched together
and reconstructed using the Nikon Elements AR 4 Software.

4.5

|

Syncytialization quantitation

In immunofluorescence images, a structure was considered a syncytium if multiple nuclei were surrounded by
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F I G U R E 9 Triplicate Western blots of upregulated genes of interest in BeWo cells -forskolin (cyt) or +forskolin (syn) and C2C12 cells in
differentiation media for 0d (mb) or 6d (mt). Blots are grouped with the actin blot that was used for their normalization. hCGb and myosin heavy
chain (MHC) are included as markers of syncytialization in BeWo cells and differentiation in C2C12 cells, respectively

a single cell membrane. Syncytialization was quantified
by counting the total number of nuclei and the number of
nuclei in syncytia in five images of each of the six conditions shown in Figure 7. Data for each condition were
combined and percentages of nuclei in syncytia were
calculated.

4.6

|

Statistical analysis

Statistical analysis, SEM, and t-test comparisons were performed using ANOVA software. Significance is p < .05.

4.7

|

RNA-Seq

Total RNA was isolated from BeWo and C2C12 cells using
the RNeasy Plus Mini Kit (Qiagen) according to the manufacturer's instructions. QIAshredder was used for homogenization. The amount of total RNA extracted was quantified on a
NanoDrop 2000 spectrophotometer and RNA quality and purity were further evaluated using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, US). RNA-Seq was
performed at the Genome Technology Access Center in the
Department of Genetics at Washington University School of
Medicine (Azar et al., 2018). Briefly, ribo-depleted libraries
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were prepared from the RNA, and samples were indexed
and sequenced on an Illumina HiSeq 2500. Sequencing results from this study have been deposited in the NCBI Short
Read Archive under accession number PRJNA397241 and
PRJNA54661. Raw reads were pseudo-aligned using kallisto
version 0.42.4 using options “—single –b 10 –l 220 –s 20”
(Bray et al., 2016).

4.8

|

Bioinformatic analysis

All analyses were performed in R version 3.2.1.
Transcript abundance was determined by sleuth (Pimentel
et al., 2017) and measured in transcripts per million
(TPM). To determine which transcripts were differentially expressed, we applied a filter requiring a transcript
to be expressed at or above the 85th percentile in at least
one sample and have a 2.5-fold change in expression between syncytiotrophoblast samples and cytotrophoblast
samples and likewise between myoblast samples and
myotube samples. Differential gene expression was determined by comparing C2C12 (0d) (mb) to C2C12 (6d)
(mt) using the EdgeR package in R(Robinson et al., 2010)
(EdgeR Data File) and the CuffLinks package (Trapnell
et al., 2012, 2013) (CuffLinks Data File). To generate the
heat maps, one sample was designated as the index and
used to sort the transcripts. The transcript levels for every
other sample were ordered according to this index sample
and displayed as log (TPM).
Gene list enrichment was performed using the PANTHER
(Mi et al., 2016) online suite of tools. We provided a list of
the most significant genes as input. The resulting gene ontology categories were reported. The default setting of the
PANTHER analysis is to perform a Bonferroni correction
for multiple test correction. Thus, the reported results are unlikely to be false positives.
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